Merck Shares Fall After Losing Vioxx Trial: "Shares of Merck & Co. fell Thursday after a New Jersey jury found that the drugmaker concealed the dangers of its painkiller Vioxx in a split verdict that gave one of two plaintiffs in the trial $4.5 million in compensatory damages.
Shares of Merck, which is facing many similar lawsuits, fell $1.47, or 4 percent, to $34.52 in early trading on the New York Stock Exchange ." [Leading the Charge]
